BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 3933332)

  • 1. T-cell subpopulations in patients with monoclonal gammopathies: essential monoclonal gammopathy, multiple myeloma, and Waldenstrom macroglobulinemia.
    San Miguel JF; Caballero MD; Gonzalez M
    Am J Hematol; 1985 Nov; 20(3):267-73. PubMed ID: 3933332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cells in monoclonal gammopathies.
    Mellstedt H; Holm G; Pettersson D; Björkholm M; Johansson B; Lindemalm C; Peest D; Ahre A
    Scand J Haematol; 1982 Jul; 29(1):57-64. PubMed ID: 6214842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of lymphocyte subpopulations in multiple myeloma and monoclonal gammopathies of undetermined significance].
    Luraschi A; Fedeli P; Rossi M; Montanara S; Perlasca S; Cozzi S
    Minerva Med; 1986 Jun; 77(26):1235-41. PubMed ID: 3088491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell subsets in malignant lymphomas and monoclonal gammopathies.
    Bergmann L; Mitrou PS; Kelker W; Weber KC
    Scand J Haematol; 1985 Feb; 34(2):170-6. PubMed ID: 3156399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Subsets of T cells in myeloma, macroglobulinemia and benign monoclonal gammopathy: analysis of surface markers defined by monoclonal antibodies and the effect on Ig-synthesis by B cells].
    Okagawa K; Iguchi K; Iishi Y; Kosaka M
    Nihon Ketsueki Gakkai Zasshi; 1985 Aug; 48(5):1205-13. PubMed ID: 3934898
    [No Abstract]   [Full Text] [Related]  

  • 6. Current concepts on monoclonal gammopathies.
    Kyle RA
    Aust N Z J Med; 1992 Jun; 22(3):291-302. PubMed ID: 1497556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imbalances of T-cell subsets in monoclonal gammopathies.
    Bergmann L; Mitrou PS; Weber KC; Kelker W
    Cancer Immunol Immunother; 1984; 17(2):112-6. PubMed ID: 6331877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom's macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significance.
    Pilarski LM; Andrews EJ; Serra HM; Ledbetter JA; Ruether BA; Mant MJ
    Am J Hematol; 1989 Feb; 30(2):53-60. PubMed ID: 2536515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When a Monoclonal Gammopathy Is Not Multiple Myeloma.
    Derman B; Castillo JJ; Sarosiek S; Beksac M
    Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-10. PubMed ID: 35394823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M protein idiotype in patients with monoclonal gammopathies.
    Sugai S; Shimizu S; Konda S
    Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1749-56. PubMed ID: 3105208
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoclonal antibody-defined T lymphocyte subpopulations in monoclonal gammapathy of undetermined significance.
    Cunietti E; Galli M; Ottomano C; Negri C; Soldini L; Scapellato L; Sensalari G
    Ric Clin Lab; 1987; 17(4):301-8. PubMed ID: 3501877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders.
    Morra E; Cesana C; Klersy C; Barbarano L; Varettoni M; Cavanna L; Canesi B; Tresoldi E; Miqueleiz S; Bernuzzi P; Nosari AM; Lazzarino M
    Leukemia; 2004 Sep; 18(9):1512-7. PubMed ID: 15322559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiology of monoclonal gammopathies].
    Hurez D
    Rev Prat; 1993 Feb; 43(3):271-4. PubMed ID: 8502953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The OKT4/OKT8 ratio in benign monoclonal gammopathies].
    La Rosa L; Mattoni C; La Rosa M
    Minerva Med; 1988 Dec; 79(12):1049-50. PubMed ID: 2974933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell subsets defined by monoclonal antibodies in monoclonal gammopathy of undetermined significance (MGUS).
    Cavanna L; Di Stasi M; Fornari F; Civardi G; Binelli F; Buscarini E; Buscarini L
    Tumori; 1985 Dec; 71(6):543-6. PubMed ID: 2934880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloma and macroglobulinemia: what are the criteria for diagnosis?
    Stone MJ
    Clin Lymphoma; 2002 Jun; 3(1):23-5. PubMed ID: 12141951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurologic manifestations of monoclonal gammapathies].
    Uldry PA; Steck AJ; Regli F
    Schweiz Med Wochenschr; 1984 Nov; 114(47):1678-85. PubMed ID: 6096963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of immune status to infectious agents in elderly patients with multiple myeloma, Waldenstrom's macroglobulinemia, and monoclonal gammopathy of undetermined significance.
    Karlsson J; Andréasson B; Kondori N; Erman E; Riesbeck K; Hogevik H; Wennerås C
    Clin Vaccine Immunol; 2011 Jun; 18(6):969-77. PubMed ID: 21508164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal gammopathies of undetermined significance.
    Kyle RA; Lust JA
    Semin Hematol; 1989 Jul; 26(3):176-200. PubMed ID: 2506645
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum markers in the differential diagnosis of Waldenstrom macroglobulinemia and other IgM monoclonal gammopathies.
    Zou H; Yang R; Liao ZX; Qin TD; Chen P; Zhang BY; Cao YP; Huang HF
    J Clin Lab Anal; 2019 Mar; 33(3):e22827. PubMed ID: 30485557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.